{
    "code": 0,
    "data": [
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "1f17125c-2084-4cee-99af-78bf07ea4502",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication on February 07 2026 with respect to the unaudited Financial results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fc8dba1-0879-40b6-8c4a-4fdb6ac2552d.pdf",
            "news_date": "2026-02-07 16:24:13"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "news_id": "bcd2daa8-4fbb-422b-b8ab-64a5d9e09cc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56d4b8f1-0961-4159-8c1d-1ddee8378747.pdf",
            "news_date": "2026-02-06 18:33:45"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about copy of Newspaper publication with respect to Second reminder for payment of the First Call money - Rights issue (Partly paid shares)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4668db9-8320-4bd0-9012-b523685b6a7d.pdf",
            "news_date": "2026-02-06 15:56:42"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation in funds raised through Rights issue for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f242718-9284-403a-b6f4-7bb36c3613bc.pdf",
            "news_date": "2026-02-06 14:36:48"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies.",
            "news_body": "The Company has reviewed and adopted the revised \" Policy for Determining Materiality of Events/Information for Disclosure to the Stock Exchanges\" and \"Policy for Governance of Related Party Transactions\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad97f977-6219-4de8-9143-f958bd383d44.pdf",
            "news_date": "2026-02-06 14:24:10"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Press release dated February 06 2026 titled \"Solara Announces Q326 Financial Results.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0374765f-df10-426d-8fea-c7169b10261a.pdf",
            "news_date": "2026-02-06 14:07:41"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "news_id": "8f5027c1-d448-4ffd-965b-6c16a06eeabe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Advertisement published with respect to dispatch of the notice of Postal Ballot dated February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3dfe2518-3939-485e-89fd-75dde57434fa.pdf",
            "news_date": "2026-02-05 18:24:24"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of Second Reminder Notice For Payment Of First Call Money",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Second Reminder Notice for payment of First call under Rights issue.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dfd4635-b92e-4555-9021-4eadda19cd0e.pdf",
            "news_date": "2026-02-04 23:10:22"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Notice of Postal Ballot dated February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e0adda2-442b-4bce-860c-9d332763cef0.pdf",
            "news_date": "2026-02-04 22:52:42"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Revised Intimation of Schedule of Analyst / Institutional Investor call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on Friday February 06 2026 at 3:30 P.M. to discuss the Companys unaudited financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73cf30f-974f-4d75-9970-605022016c2a.pdf",
            "news_date": "2026-02-03 14:59:29"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday February 06 2026 to discuss the Companys unaudited financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797c3033-9b64-4a7c-b667-0badd701137f.pdf",
            "news_date": "2026-01-30 20:27:50"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2607bf68-fabd-44c1-a369-c14f5d9aa2ef.pdf",
            "news_date": "2026-01-12 15:30:41"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding closure of Trading Window for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bc5bd7e-b196-42eb-aed0-1970414992ab.pdf",
            "news_date": "2025-12-24 13:01:30"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 1500 shares pursuant to exercise of ESOP options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a38a443-ad2a-4b0c-9bbb-7ac90f9b1e91.pdf",
            "news_date": "2025-12-17 11:49:35"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reconstitution Of The Management Committee",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the reconstitution of the Management Committee.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a39fb621-8abf-4ce1-8fac-bc27498f4e42.pdf",
            "news_date": "2025-12-17 11:14:27"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding appointment of Mr. Mohanraj S(DIN: 08420411) as Additional Executive Director and Whole Time Director with effect from January 01 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e8967e0-957a-43e6-be72-e8cbf203df69.pdf",
            "news_date": "2025-12-17 11:01:09"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Resignation of Mr. Mohan Muthunarayanan (DIN: 03610282)Whole Time Director & Chief Operating Officer of the company with effect from the end of business hours on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6913bca-7e10-464f-a529-e7e6e28714f9.pdf",
            "news_date": "2025-12-05 18:14:08"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Volume Movement",
            "news_body": "Clarification in relation to the mail received from exchange on December 04 2025 on Volume Movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ce663b2-80e6-4c9e-9dad-ab98a88b7800.pdf",
            "news_date": "2025-12-04 13:50:10"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the Press release titled \"Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore facility with continued state of compliance on cGMP.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28b667e5-dc09-4162-b483-e8b65fc61c41.pdf",
            "news_date": "2025-11-19 10:19:40"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "news_id": "0565c206-6232-408b-88a5-efc6139888b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publications w.r.t. Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43130d62-6a3c-4a00-a869-57e8350c0845.pdf",
            "news_date": "2025-11-06 19:02:25"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e404eba8-7d41-4eeb-bfa5-f07ac06d3ae7.pdf",
            "news_date": "2025-11-06 18:25:55"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "news_id": "684c346f-e82f-4bcb-ad81-8f95b8215a9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:51",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:51"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General-Updates",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the following items approved at the Board Meeting held on November 05 2025: \r\n\r\n1. Appointment of Mr. Sarat Kumar Asuri CFO as the Chief Investor Relations Officer.\r\n\r\n2. Change in remuneration of the Whole Time Director Mr. Mohan Muthunarayanan.\r\n\r\n3. Change in the remuneration of the eligible Senior Management Personnels.\r\n\r\n4. Review and confirmation of Risk Management Policy.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66f76cc5-79a6-4f5f-8d1f-9196fa286fbf.pdf",
            "news_date": "2025-11-05 15:38:21"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 8040 Equity shares pursuant to the exercise of ESOP Options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0eba826-b98f-40d3-bbc9-b4c3589e5634.pdf",
            "news_date": "2025-11-05 15:19:23"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation in Funds raised through Rights Issue for the quarter ending September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8937b40c-4fdb-4e42-9070-793158dc5bac.pdf",
            "news_date": "2025-11-05 15:16:14"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding The Grant Of ESOP",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the grant of 25000 Employee Stock Options under Solara Employee Stock Option Scheme 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee639b10-d70c-499e-bc9a-680f638a24e8.pdf",
            "news_date": "2025-11-05 15:02:10"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation About Appointment Of Mr. Mohanraj S As Chief Human Resources Officer (CHRO)",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Mohanraj S as Chief Human Resources Officer (CHRO) and designated him as Senior Management Personnel with effect from November 05 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab71aa26-c5d9-4352-bfd2-db6d3de0b2f4.pdf",
            "news_date": "2025-11-05 14:50:56"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated November 05 2025 titled \"Solara Q226 Performance\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b27a99c9-58ce-4cba-bff2-6095b3027384.pdf",
            "news_date": "2025-11-05 14:44:18"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Resignation of Non Executive Non Independent Director Mr. Kartheek Chintalapati Raju w.e.f the end of business hours of November 05 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98179e13-cf69-4a71-980f-e474e6f82b57.pdf",
            "news_date": "2025-11-05 14:31:27"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "news_id": "4aab579b-2157-4ec8-9893-b220906f0d15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the Analyst / Investors call to be held on Wednesday November 052025 at 15.30 P.M. IST to discuss the Companys unaudited financial results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=119ca60b-c47b-43e1-84c5-9ba62b341450.pdf",
            "news_date": "2025-10-30 21:49:51"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Rating By CRISIL",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the ESG rating received from Crisil ESG Ratings & Analytics Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5405a967-e6b3-41b8-94af-d5838ce6134c.pdf",
            "news_date": "2025-10-17 11:19:39"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9a2c897-fd59-4f84-88c7-8e22a34cea89.pdf",
            "news_date": "2025-10-16 15:55:05"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of shares pursuant to exercise of ESOP Options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cc3cd76-a765-4132-aec4-7cadba714620.pdf",
            "news_date": "2025-10-13 23:57:24"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the Newspaper publication regarding Intimation of 100 days campaign - \"Saksham Niveshak\" and Notice Intimating the shareholders about the opening of a special window for Re - lodgement of transfer requests of physical shares and request for KYC updation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d385d45-7353-442c-8a3b-a5e6fce7fd8a.pdf",
            "news_date": "2025-10-09 17:49:37"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Stock exchange regarding the Voting Results and Scrutinizers Report of the 8th Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb3baf0f-e3c3-4df7-a266-ee32adaf0f31.pdf",
            "news_date": "2025-09-29 17:19:13"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding the closure of Trading Window for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e79afa18-7000-4b55-ad7d-af7526c08cfc.pdf",
            "news_date": "2025-09-26 21:46:26"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 SEBI (LODR) - Clarification",
            "news_body": "Clarification in relation to mail received from BSE on Volume Movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdc905b2-ca51-4bc2-b223-84f1dcbf596c.pdf",
            "news_date": "2025-09-26 14:00:22"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Solara Active Pharma Sciences Limited - Proceedings of the Eighth Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56fddd72-7d63-41ef-b9c1-975a96ef7f58.pdf",
            "news_date": "2025-09-25 20:02:09"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Post Dispatch Newspaper Publication of 8th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2673aa72-8aed-4241-9fb4-84f373a07f4e.pdf",
            "news_date": "2025-09-03 16:23:45"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Post Dispatch Newspaper Publication of 8th AGM Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f674319-d5bd-48c7-ae01-72b07e7cd73b.pdf",
            "news_date": "2025-09-03 16:10:48"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the financial year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bbffa58-b59b-4de4-8e6d-13b9dfcd0aef.pdf",
            "news_date": "2025-09-02 21:30:10"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=570e7d90-62b4-4036-87a2-8db374479e32.pdf",
            "news_date": "2025-09-02 21:24:18"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of The 8Th Annual General Meeting",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of 8th Annual General Meeting (\"AGM\") of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f87743b3-f6de-4161-a650-1a527d24e7b9.pdf",
            "news_date": "2025-09-02 21:05:44"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Stock Exchange regarding the Newspaper Publication with respect to Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fe5d6f4-27e0-4504-b4b0-a231abed893c.pdf",
            "news_date": "2025-09-01 17:18:58"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding 100 Days Campaign - Saksham Niveshak",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding intimation to shareholders as per the 100 Days Campaign - \"Saksham Niveshak\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e2bd4e-7232-4284-b555-b4b94731c354.pdf",
            "news_date": "2025-08-21 19:05:25"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of Call Money Pursuant To The First Reminder Notice Issued For Payment Of First Call Money On The Outstanding Partly Paid-Up Rights Equity Shares Of The Company.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the receipt of first call money pursuant to the First Reminder Notice issued for payment of first call money on the outstanding partly paid Rights Equity Shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361b198f-ccbe-4da7-9a51-ed49acf79dcf.pdf",
            "news_date": "2025-08-16 13:05:26"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended June 30 2025 received from CRISIL Ratings Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c408e53b-b4b2-4c19-8280-dce74d9f7d1e.pdf",
            "news_date": "2025-08-13 15:56:40"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "news_id": "3e2a7da4-1e02-43d7-a772-a531839721b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Newspaper publication made on July 26 2025 wherein the Financial Results for the quarter ended June 30 2025 has been published.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b971ac89-70c3-490f-8eba-162daea2af82.pdf",
            "news_date": "2025-07-26 16:36:00"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about Link of Recording of the Investors meet held on 25th July 2025 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4629c965-465b-4690-a330-612c95b3a6bc.pdf",
            "news_date": "2025-07-25 18:43:06"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated July 25 2025 titled   \" Solara Q1 26 Performance\" of the Board Meeting held today i.e. July 25 2025 to consider the unaudited financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7608b701-8298-43fb-b889-9762cce8f6cc.pdf",
            "news_date": "2025-07-25 15:25:11"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights issue for Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75db47d5-0ece-4b76-acfd-4ef2cae259cb.pdf",
            "news_date": "2025-07-25 13:40:16"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "news_id": "3139ced0-a554-4e77-8f0f-057bd0c2d406",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of Investors/Analyst call to be held on Friday 25th July 2025 at 4.00P.M.  to discuss the Companys financial results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0e57803-5046-4fb4-833c-47ec8277a6e3.pdf",
            "news_date": "2025-07-21 16:57:22"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb8cd94a-05e9-4edf-b8bb-5aeda69fa848.pdf",
            "news_date": "2025-07-17 17:35:36"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "This is to inform that Solara Active Pharma Sciences Limited has made a Newspaper Publication on July 05 2025 as a reminder to encash the unpaid Sale proceed of Fractional Shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f3ce8f-b290-42ad-a268-7553082a189b.pdf",
            "news_date": "2025-07-07 16:52:14"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the copy of the Newspaper publication made by the Company with respect to dispatch of first reminder notice for payment of First Call Money",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f8751b-1e06-4383-b8f4-219d775d94d6.pdf",
            "news_date": "2025-07-03 14:40:33"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of First Reminder Notice For Payment Of First Call Money",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about the dispatch of First Reminder Notice for payment of First Call Money sent on July 01 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c91a7f-f7c0-488e-87d4-001f19710557.pdf",
            "news_date": "2025-07-02 11:49:12"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Solara Active Pharma Sciences Limited has informed Stock Exchange regarding Credit Rating received from Crisil Ratings Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7782219c-d0dc-4da5-a925-0dcee307ef02.pdf",
            "news_date": "2025-07-01 17:19:46"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Solara Active Pharma Sciences Limited has informed the stock exchange regarding the Trading Window Closure with effect from July 01 2025 pursuant to SEBI(Prohibition of Insider Trading) Regulations 2015 for considering the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a65ea5f8-4965-4520-ac48-b434778ef495.pdf",
            "news_date": "2025-06-27 15:34:57"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Newspaper publication for transfer of unclaimed shares to IEPF account",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74d92a3c-1b7d-4843-8fc2-7139bb10e371.pdf",
            "news_date": "2025-05-28 17:35:23"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the submission of Annual Secretarial Compliance report for the year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7152c15e-a66e-4635-a648-5e78bee3654d.pdf",
            "news_date": "2025-05-28 17:31:05"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "news_id": "1e2a1478-18ed-44cd-a999-e2e160de1d2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited hereby informed the exchange on the newspaper publication made on May 16 2025 wherein the Financial Results for the quarter and year ended March 31 2025 were published.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab77fef6-523a-42ae-81fe-0ab7e0c3a399.pdf",
            "news_date": "2025-05-16 13:26:47"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the outcome of the Investors conference call for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0a43c95-b207-4809-a69a-3287d23632e0.pdf",
            "news_date": "2025-05-15 19:43:17"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Internal Auditors Secretarial Auditor And Reappointment Of Cost Auditor.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Appointment of Internal Secretarial Auditor and Reappointment of Cost Auditor in the Board Meeting held on May 15 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02a59773-2cff-4408-a743-979c3749203f.pdf",
            "news_date": "2025-05-15 17:30:01"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment of Company Secretary Compliance officer and Key Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e817c667-e6db-4947-a4ca-13359becfe42.pdf",
            "news_date": "2025-05-15 17:14:34"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Retirement",
            "caption": "Announcement under Regulation 30 (LODR)-Retirement",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Retirement of Company Secretary and Compliance officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=116cf05e-1cb4-478c-87c2-6d5d09af546f.pdf",
            "news_date": "2025-05-15 17:11:11"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding Resignation and Appointment of Company Secretary and Compliance officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85d3daa9-d661-470d-be71-9793bd962bfe.pdf",
            "news_date": "2025-05-15 16:55:16"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Statement Of Deviation And Variation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange that there is no Deviation and Variation of Funds raised through Rights Issue for Quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e715b48-e062-4b82-bbbf-0fcd30379fc9.pdf",
            "news_date": "2025-05-15 16:43:41"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Press Release for the Board Meeting held on May 15 2025 on Q4 of FY 25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b77fcb83-d70c-4b22-88a5-3d62939d6795.pdf",
            "news_date": "2025-05-15 16:41:25"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "news_id": "945382a7-b56f-4e81-9560-9af3a5c43e7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 - Press Release",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the press release of completion of USFDA Inspection in Ambernath facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e6cf5f-61dc-45c1-9228-19873722a95f.pdf",
            "news_date": "2025-05-10 15:40:33"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday May 15 2025 at 3:30 PM to discuss the Companys Financial results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd45bff9-f7cb-4eb3-917d-294f5cead860.pdf",
            "news_date": "2025-05-08 12:53:32"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding submission of Monitoring Agency Report for the quarter ended March 31 2025 received from CRISIL Ratings Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0556508-77bd-41aa-a3ec-a0cf28757920.pdf",
            "news_date": "2025-05-07 13:13:06"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Corporate Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Corporate Office Address",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in Corporate Office address.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c248ed0-5c28-475e-a0e9-03144f8aa80f.pdf",
            "news_date": "2025-05-05 14:59:13"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Change in the Registered Office of the Company within the local limits of the City.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3bd0410-c118-4ba3-8e46-d6a75d2eaa02.pdf",
            "news_date": "2025-05-05 14:55:16"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Incorporation Of Wholly Owned Subsidiary Company",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Incorporation of Wholly Owned Subsidiary Company in the name of \"Synthix Global Pharma Solutions Limited\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee259107-7772-46b1-bb8a-fee679d21d2b.pdf",
            "news_date": "2025-04-29 16:18:25"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b33f6925-2058-42f4-8196-3e5ed9f32111.pdf",
            "news_date": "2025-04-17 15:54:59"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about Copy of the Newspaper publications made by the Company on the Record date fixed for the purpose of dispatch of the First Call Notice to the eligible shareholders",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e409f7-eccf-4a00-844b-371cc92a721c.pdf",
            "news_date": "2025-04-09 13:35:34"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Notice On The First Call Money Of The Rights Equity Shares.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about dispatch of Notice to the eligible shareholders of the First Call Money of the Rights Equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8239b84e-d5b5-4bbd-99f6-becff944353d.pdf",
            "news_date": "2025-04-09 13:34:19"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
            "news_body": "Solara Active Pharma Sciences Limited informed the exchange about the outcome of the Rights Issue Committee Meeting held today (i.e.) April 02 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5547a8d5-ffdd-4974-bb3b-40af3b51a719.pdf",
            "news_date": "2025-04-02 15:54:41"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure with effect from April 1 2025 pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 for considering the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16c8c60b-ee5e-473e-b841-26a24b3e93d3.pdf",
            "news_date": "2025-03-26 16:03:25"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For The Purpose Of Making First Call For Rights Issue Equity Shares",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about the Record date for the purpose of making first call for the shares issued on Rights Basis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c79e8e36-c29a-46b4-a2dc-16ea133dc457.pdf",
            "news_date": "2025-03-26 11:16:18"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
            "news_body": "Solara Active Pharma Sciences Limited had informed the Exchange that Rights Issue Commitee Meeting of the Board of Directors at its meeting held on March 26 2025 has approved the making of first call of Rs. 3.50/- each (i.e.) 35% on the face value of Rs. 10/- each on the outstanding 11998755 partly paid up equity shares of the Company which were allotted on June 19 2024 on a rights basis and fixation of Record date tendering period and other matters",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abefa786-8f54-403f-b552-608668e42089.pdf",
            "news_date": "2025-03-26 10:54:10"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange about copy of Newspaper Publication published in \r\n1. Business Standard (English Version)\r\n2. Pratahkal (Marathi Version)\r\non Friday March 21 2025 with respect to completion of dispatch of Postal Ballot Notice dated March 20 2025 to the Members of the Company \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac6ed593-3cf6-467d-a1ab-f04cb01f7e89.pdf",
            "news_date": "2025-03-21 13:36:46"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of the Postal Ballot of the Company for obtaining Members approval to consider the appointment of Mr. Sandeep Shashikantha Rao as a Managing Director and Chief Executive Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8bc8e49-cf39-4007-92f5-0e80a5235679.pdf",
            "news_date": "2025-03-20 15:56:59"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of ESOP Options",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange about Grant of ESOP Options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0970decc-0f42-4a59-810b-24fc5a03be96.pdf",
            "news_date": "2025-02-21 17:58:01"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Closure Of Wholly Owned Subsidiary",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Closure of Wholly Owned Subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1c7fb0e-ef9c-459a-88df-a5fd3010537c.pdf",
            "news_date": "2025-02-21 17:51:57"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Managing Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Managing Director",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Resignation of Managing Director.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=873dccf8-3841-452e-ac8c-eb41a84b116b.pdf",
            "news_date": "2025-02-21 17:39:06"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment and Resignation of Chief Executive officer Appointment and Resignation of Chief Financial Officer Appointment of a Senior Managerial Personnel.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0b7ca77-3fc2-44fd-ab9c-9e6ebee260e6.pdf",
            "news_date": "2025-02-21 17:32:35"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Solara Active Pharma Sciences has informed the Exchange regarding the appointment of a Managing Director.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab346edb-f328-42f3-a951-4f0e5312dd46.pdf",
            "news_date": "2025-02-21 17:24:17"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Monitoring Agency Report for the quarter ended December 31 2024 received from CRISIL Ratings Limited is being submitted.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03b70687-6d5e-4922-afa3-4017db1bc61a.pdf",
            "news_date": "2025-02-10 15:04:15"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
            "news_body": "The Company in their Board Committee meeting held today (i.e.) February 07 2025 considered the proposal to Incorporate a wholly - owned subsidiary Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ebaae09-c795-492d-9c4a-2466b034e49c.pdf",
            "news_date": "2025-02-07 10:32:11"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on January 24 2025.",
            "news_id": "87bd207b-560c-4c83-b1b3-d23e914aaaba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf",
            "news_date": "2025-01-31 14:57:08",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93253,
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on January 24 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf",
            "news_date": "2025-01-31 14:57:08"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31 2024 and other matters.",
            "news_id": "38d3cdfe-032c-4b86-8c0b-44fa0a030861",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf",
            "news_date": "2025-01-24 14:46:27",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}